Literature DB >> 7576303

VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment.

J M Muller1, V Lelievre, L Becq-Giraudon, A C Meunier.   

Abstract

In addition to its commonly recognized status as a neuromodulator of virtually all vital functions, including neurobiological, the neuropeptide VIP plays a role in the control of cell growth and differentiation and of neuronal survival. Through these actions, VIP, whose impact appears early in ontogeny, may possess developmental functions. VIP can be stimulatory or inhibitory on cell growth in function of the model considered. The growth regulatory actions of VIP, which are often independent of cAMP, are most likely significant when mitogenic or trophic factors, eventually released by nontarget cells, are simultaneously present in the extracellular medium. The intracellular mechanisms that mediate these actions of VIP may involve different transduction cascades triggered by subsets of VIP binding sites that may coexist in the same tissue.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576303     DOI: 10.1007/BF02740671

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  110 in total

Review 1.  Nitric oxide, a novel neuronal messenger.

Authors:  D S Bredt; S H Snyder
Journal:  Neuron       Date:  1992-01       Impact factor: 17.173

2.  Vasoactive intestinal peptide gene expression from embryos to aging rats.

Authors:  I Gozes; P Schächter; Y Shani; E Giladi
Journal:  Neuroendocrinology       Date:  1988-01       Impact factor: 4.914

Review 3.  Biosynthesis and regulation of expression. The vasoactive intestinal peptide gene.

Authors:  I Gozes
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

Review 4.  HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.

Authors:  G Marchis-Mouren; J M Martin; J Luis; A el Battari; J M Muller; J Marvaldi; J Pichon
Journal:  Biochimie       Date:  1988-05       Impact factor: 4.079

5.  Retinoic acid enhances VIP receptor expression and responsiveness in human neuroblastoma cell, SH-SY5Y.

Authors:  J A Waschek; J M Muller; D S Duan; W Sadée
Journal:  FEBS Lett       Date:  1989-07-03       Impact factor: 4.124

6.  Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter.

Authors:  T Yamagami; K Ohsawa; M Nishizawa; C Inoue; E Gotoh; N Yanaihara; H Yamamoto; H Okamoto
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

7.  Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide.

Authors:  T Ishihara; R Shigemoto; K Mori; K Takahashi; S Nagata
Journal:  Neuron       Date:  1992-04       Impact factor: 17.173

8.  Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma.

Authors:  M S O'Dorisio; D J Fleshman; S J Qualman; T M O'Dorisio
Journal:  Regul Pept       Date:  1992-02-18

9.  The action of vasoactive intestinal peptide antagonists on peptidergic modulation of the squid Schwann cell.

Authors:  P D Evans; J Villegas
Journal:  J Exp Biol       Date:  1988-09       Impact factor: 3.312

10.  Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide.

Authors:  D E Brenneman; E A Neale; G A Foster; S W d'Autremont; G L Westbrook
Journal:  J Cell Biol       Date:  1987-06       Impact factor: 10.539

View more
  7 in total

1.  Microarray analyses of pituitary adenylate cyclase activating polypeptide (PACAP)-regulated gene targets in sympathetic neurons.

Authors:  Karen M Braas; Kristin C Schutz; Jeffrey P Bond; Margaret A Vizzard; Beatrice M Girard; Victor May
Journal:  Peptides       Date:  2007-04-19       Impact factor: 3.750

2.  MAPT isoforms: differential transcriptional profiles related to 3R and 4R splice variants.

Authors:  Shufen Chen; Kirk Townsend; Terry E Goldberg; Peter Davies; Concepcion Conejero-Goldberg
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Irradiation induces marked immunohistochemical expression of vasoactive intestinal peptide in colonic mucosa of man.

Authors:  U Höckerfelt; R Henriksson; L Franzén; O Norrgård; S Forsgren
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

Review 4.  Niosomes: a novel targeted drug delivery system for cancer.

Authors:  Maryam Moghtaderi; Kamand Sedaghatnia; Mahsa Bourbour; Mahdi Fatemizadeh; Zahra Salehi Moghaddam; Faranak Hejabi; Fatemeh Heidari; Sameer Quazi; Bahareh Farasati Far
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

5.  Effects of the vasoactive intestinal peptide (VIP) and related peptides on glioblastoma cell growth in vitro.

Authors:  Christine Dufes; Céline Alleaume; Alicia Montoni; Jean-Christophe Olivier; Jean-Marc Muller
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

6.  GABA networks destabilize genetic oscillations in the circadian pacemaker.

Authors:  G Mark Freeman; Rebecca M Krock; Sara J Aton; Paul Thaben; Erik D Herzog
Journal:  Neuron       Date:  2013-06-05       Impact factor: 17.173

7.  Antagonism of VIP-stimulated cyclic AMP formation in chick brain.

Authors:  Jerzy Z Nowak; Paulina Sedkowska; Jolanta B Zawilska; Illana Gozes; Douglas E Brenneman
Journal:  J Mol Neurosci       Date:  2003-04       Impact factor: 3.444

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.